APPOS - Los Angeles


July 29th - July 30th, 2022

Agenda

Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.

All Times Listed are for the Pacific Standard Time Zone

Friday, July 29, 2022

7:00am Check-in & Breakfast Available in Exhibit Hall
8:00am Horizon CME App Overview
8:10am Welcome, Introductions, & CE Housekeeping
8:15am (01) Financial Toxicity of Cancer Care: How Can We Assist Patients?
» Jason Astrin, DMSc, MBA, PA-C, DFAAPA - The US Oncology Network
9:15am (02) Provider Burnout: Is Resilience the Answer?
» Erin Kopp, MSN, ACNP-BC, NP - City of Hope
10:15am Break | Refreshments in Exhibit Hall
10:45am (03) Non-Small Cell Lung Cancer: Reframing the Treatment Landscape
» Jennifer Dvorak, MSN, FNP-BC - University of CA, San Diego
11:45am Gather Lunch
11:50am Buffet Lunch & Non-CME/CE Presentation Sponsored by Incyte-Jakafi: Real-World Case Discussion WHEN TO INTERVENE WITH JAKAFIĀ® (ruxolitinib) In Adults With Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea
» Rhonda Hewitt, NP - Stanford Cancer Center
12:40pm After Lunch Dessert Break in Exhibit
1:00pm (04) Pancreatic Adenocarcinoma: New Approaches in Treatment with a Focus on Targeted Therapy
» Zev A. Wainberg, MD - UCLA School of Medicine
2:00pm Break | Refreshments in Exhibit Hall
2:20pm (05) Novel Therapies in Head and Neck Squamous Cell Carcinoma  
» Deborah Wong, MD, PhD - UCLA Medical Center
3:20pm (06) Cancer-Related Thrombosis: A Debate on the Best Way to Anticoagulate
» Allison Schepers, PharmD - University of Michigan
» Shawn Griffin, PharmD - UC Irvine
4:35pm Networking Reception

Saturday, July 30, 2022

7:00am Check-in & Breakfast Available in Exhibit Hall
7:10am Morning Symposium - Sponsored by Pfizer Oncology
Clinical Trial Evidence for a CDK4/6 Inhibitor Combination Therapy Complemented by an Evaluation of Real-World Effectiveness
» Kimberly C. Podsada, RN, MSN, NP-C, OCN - University of California, San Diego Moores Cancer Center
8:00am Horizon CME App Overview
8:10am Welcome, Introductions, & CE Housekeeping
8:15am (07) COVID-19 and Cancer: Where Are We Now?
» Abigail Martin, MSN, NP-C - City of Hope Medical Center
9:15am (08) Expanding Therapeutic Options in Multiple Myeloma
» Murali Janakiram, MD - City of Hope
10:15am Break | Refreshments in Exhibit Hall
10:45am (09) Treating B-cell Lymphoma in the Era of New Agents
» Yi-Ping Wen, MSN, FNP-C - City of Hope
11:45am Gather Lunch
11:50am Buffet Lunch & Non-CE Symposium Presentation Sponsored by Taiho Oncology: LONSURF® (trifluridine and tipiracil) tablets: Oral chemotherapy for previously treated metastatic colorectal, gastric and gastroesophageal (GEJ) cancers
» May Cho, MD
12:40pm Dessert Break in Exhibit Hall
1:00pm (10) Recent Progress in Cancer Drug Development: New Agents and New Strategies to Optimize Care
» Julie Guglielmo, PharmD, BCOP - UC Davis
2:00pm Break | Refreshments in Exhibit Hall
2:20pm (11) MRD : Emerging Prognostic Biomarker in Hematologic Malignancies
» Gary Schiller, MD - UCLA 
3:20pm Closing Comments